首页> 外文期刊>Therapeutic Drug Monitoring >Stability of sufentanil in human plasma samples.
【24h】

Stability of sufentanil in human plasma samples.

机译:舒芬太尼在人血浆样品中的稳定性。

获取原文
获取原文并翻译 | 示例
           

摘要

The stability of sufentanil in human plasma kept under various storage conditions was investigated. Extraction was performed using solid phase extraction with new mixed-mode cation exchange Oasis MCX columns; quantification was carried out using gas chromatography equipped with a mass spectrometry detector. When plasma was left at 4 degrees C in nonsilanized tubes, concentrations of sufentanil decreased significantly during the first hour. In plasma samples kept at -25 degrees C for 8 hours in nonsilanized glass tubes, a significant decrease of sufentanil concentrations was found, with an average loss of 10.1% of the initial concentration. A significant decrease occurred when plasma was kept in silanized glass tubes for 12 hours at -25 degrees C. The current study emphasizes the importance of sampling and storage conditions for an accurate determination of sufentanil concentration in plasma.
机译:研究了舒芬太尼在各种保存条件下在人血浆中的稳定性。使用固相萃取和新型混合模式阳离子交换Oasis MCX柱进行萃取;使用配备有质谱检测器的气相色谱法进行定量。当血浆在非硅烷化管中于4°C放置时,舒芬太尼的浓度在第一个小时内显着下降。在未硅烷化的玻璃管中于-25摄氏度下放置8小时的血浆样品中,舒芬太尼的浓度显着下降,平均损失为初始浓度的10.1%。当血浆在-25摄氏度的温度下在硅烷化玻璃管中放置12小时时,显着下降。当前的研究强调了采样和储存条件对于准确测定血浆中舒芬太尼浓度的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号